Internal Medicine, Hematology & Oncology · Suffolk, VA
NPI
1700175288
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2790 Godwin Blvd Ste 101
Suffolk, VA, 23434
Phone (757) 539-0670
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
220,021 services
Medicare patients, 2024
939
Average age 74
Drug cost, 2024
$4.3M
1,332 prescriptions
Company payments, 2025
$1,133
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayham Deeb was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 31,620 times for 25 patients. In total Ayham Deeb billed 220,021 services in 196 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 31,620 | 25 | $2.30 | $73K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 17,300 | 22 | $44.61 | $772K |
| J9299 Injection, nivolumab, 1 mg | Office | 15,340 | 11 | $24.67 | $378K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,550 | 23 | $0.11 | $1,300 |
| J9267 Injection, paclitaxel, 1 mg | Office | 9,360 | 15 | $0.07 | $700 |
| J0185 Injection, aprepitant, 1 mg | Office | 3,120 | 11 | $1.25 | $3,885 |
| 85025 Blood Count | Office | 2,522 | 610 | $7.58 | $19K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,202 | 71 | $0.09 | $195 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,670 | 29 | $0.24 | $404 |
| 80053 Clinical Chemistry | Office | 1,600 | 491 | $10.29 | $16K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,490 | 43 | $0.74 | $1,101 |
| 36415 Venipuncture Blood Collection | Office | 1,143 | 426 | $8.60 | $9,830 |
| 83615 Clinical Chemistry | Office | 1,090 | 437 | $5.89 | $6,420 |
| 82784 Immunoassay | Office | 1,041 | 213 | $9.07 | $9,441 |
| 96375 Injection Administration | Office | 864 | 91 | $11.42 | $9,865 |
By year: 2022 $3.4M for 237,192 services; 2023 $4.0M for 258,420 services; 2024 $3.7M for 220,021 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,522 | 610 | $7.58 | $19K |
| 80053 Clinical Chemistry | 1,600 | 491 | $10.29 | $16K |
| 36415 Venipuncture Blood Collection | 1,143 | 426 | $8.60 | $9,830 |
| 83615 Clinical Chemistry | 1,090 | 437 | $5.89 | $6,420 |
| 82784 Immunoassay | 1,041 | 213 | $9.07 | $9,441 |
| 88185 Surgical Pathology Examination | 698 | 32 | $17.31 | $12K |
| 82728 Clinical Chemistry | 626 | 323 | $13.30 | $8,327 |
| 83550 Clinical Chemistry | 626 | 323 | $8.53 | $5,341 |
| 83540 Clinical Chemistry | 626 | 323 | $6.31 | $3,951 |
| 82607 Clinical Chemistry | 434 | 294 | $14.78 | $6,415 |
Medicare prescription drug claims, 2024
In 2024, the drug Ayham Deeb prescribed most often to Medicare patients was Eliquis (Apixaban), with 83 prescriptions and refills. In total Ayham Deeb wrote 1,332 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 83 | 116 | 32 | $66K |
| Lenalidomide Generic | 71 | 71 | Under 11 | $913K |
| Letrozole Generic | 69 | 106 | 21 | $1,817 |
| Potassium Chloride Generic | 61 | 67 | 20 | $523 |
| Dexamethasone Generic | 57 | 59 | 25 | $592 |
| Mirtazapine Generic | 47 | 57 | 22 | $933 |
| Furosemide Generic | 39 | 44 | 21 | $26.81 |
| Xarelto Rivaroxaban | 36 | 48 | Under 11 | $24K |
| Anastrozole Generic | 35 | 74 | 13 | $371 |
| Prednisone Generic | 33 | 35 | 16 | $131 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | 16 | $191 |
| Gabapentin Generic | 30 | 30 | 12 | $133 |
| Ondansetron Odt Ondansetron | 30 | 30 | 20 | $570 |
| Tamoxifen Citrate Generic | 30 | 49 | Under 11 | $467 |
| Revlimid Lenalidomide | 29 | 29 | Under 11 | $513K |
Brand drugs: 337 claims; generic drugs: 995 claims; opioid claims: 98.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayham Deeb $1,133 ($1,133 in general payments such as food, travel and fees) from 8 companies. The largest payer was Eisai Inc. with $246.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.